Which medication should be readily available to treat a bethanechol-induced cholinergic crisis?

Master the NLN Pharmacology Exam with our comprehensive quiz. Use flashcards and multiple choice questions with hints and detailed explanations. Elevate your pharmacology knowledge and prepare for success!

Multiple Choice

Which medication should be readily available to treat a bethanechol-induced cholinergic crisis?

Explanation:
Bethanechol overstimulates muscarinic receptors, so a cholinergic crisis presents with increased salivation, tearing, urination, bronchorrhea/bronchospasm, bradycardia, and miosis. To counteract these muscarinic effects quickly, a muscarinic antagonist is used. Atropine blocks acetylcholine at the muscarinic receptors, reversing the excess parasympathetic stimulation and rapidly alleviating the dangerous symptoms such as bradycardia and bronchorrhea. That makes it the appropriate emergency treatment to have readily available. The other options don’t target muscarinic overactivity—epinephrine helps with certain emergencies like severe allergic reactions or hypotension, while diphenhydramine and acetaminophen address allergy symptoms or pain/fever, not cholinergic toxicity.

Bethanechol overstimulates muscarinic receptors, so a cholinergic crisis presents with increased salivation, tearing, urination, bronchorrhea/bronchospasm, bradycardia, and miosis. To counteract these muscarinic effects quickly, a muscarinic antagonist is used. Atropine blocks acetylcholine at the muscarinic receptors, reversing the excess parasympathetic stimulation and rapidly alleviating the dangerous symptoms such as bradycardia and bronchorrhea. That makes it the appropriate emergency treatment to have readily available. The other options don’t target muscarinic overactivity—epinephrine helps with certain emergencies like severe allergic reactions or hypotension, while diphenhydramine and acetaminophen address allergy symptoms or pain/fever, not cholinergic toxicity.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy